As a leading supplier in the field of microarrays, CD BioGlyco is committed to designing and developing various effective biological microarray products for non-clinical research and providing corresponding testing services. Our microarray test platform provides a full range of analysis and determination services for the study of lectin-related carbohydrates and glycoproteins to help our global customers conduct relevant research and reduce research costs.
The lectin microarray consists of a set of lectins with unique glycan-binding properties printed on a solid support. The emergence of high-throughput glycomics technology enables lectin microarrays to simultaneously observe a variety of unique binding interactions, which has become the main method for studying glycosylation of entire samples. The most significant advantage of the lectin microarray over the glycan profile analysis method is that it only requires minimal sample preparation without releasing glycans, and can simultaneously quantitatively analyze different types of glycans on the complete biological structure. And these glycans can provide a global view of glycosylation status in their local environment. Lectin microarrays can be used to analyze precise glycosylation in various cells during cell development and differentiation to analyze cellular processes, including cell development and differentiation, cell-to-cell communication, pathogen host identification, and cell surface biomarker identification. In addition, it can quickly assess the real-time changes of surface carbohydrate epitopes and examine the dynamic effects of responses to external stimuli such as bacterial sugars. It can also be applied to the development of specific disease diagnostic biomarkers in clinical related research.
Our service is built upon the powerful principle of using immobilized lectins to analyze the glycan structures present in a sample. Lectins are a class of proteins that bind specifically to certain sugar structures, acting as highly specific probes for different glycan moieties. Our core technology utilizes a high-density microarray platform where an extensive panel of lectins is spotted onto a solid surface. When a biological sample, such as serum or cell lysate, is applied to the microarray, the glycoproteins present bind to their specific lectin partners. This interaction is then detected and quantified, providing a detailed glycosylation profile of the sample. To complement this, we can integrate the microarray analysis with advanced mass spectrometry (MS) to achieve an even deeper level of detail. This combined approach allows for not only a broad, high-throughput overview of the glycome but also the precise structural identification of individual glycans and their protein-binding sites.
Our microarray detection platform based on lectin microarray technology provides lectin conjugate analysis services. Our service process includes sample preparation, chemical labeling, microarray hybridization, and data analysis and processing. Our service can obtain high-throughput N or O glycan analysis maps from cell lysates or body fluids through lectin microarrays to quantify glycoprotein profiles. It can also be combined with mass spectrometry and other technologies to accurately analyze the structure and content of sugar chains or related glycoproteins bound by lectins. Our microarray service can be used to analyze the information of lectin-binding proteins as well as glycoprotein analysis. Lectin microarrays can be based on precise changes in protein sugar patterns, with minimal sample preparation without the need to release glycans, to ensure the true state of protein glycosylation in the tester's clinical samples. This helps to screen early patients with different types of cancers and correctly reflect some of the molecules in the body fluids of healthy, benign lesions and cancer that can be used as potential biomarkers. These characteristics make lectin microarrays very important for the analysis of precious clinical samples.
The process begins with the preparation of your biological samples (e.g., cell lysates or serum). Glycoproteins within the sample are then labeled, typically with a fluorescent dye, to enable detection on the microarray surface. This step ensures a strong and clear signal for subsequent analysis.
The prepared and labeled samples are incubated on our proprietary lectin microarrays. The glycoproteins bind to their specific lectin probes on the array. Our comprehensive panel of lectins ensures a wide-ranging analysis of different glycan structures present in your sample.
After incubation and washing, the microarray slides are scanned with a high-sensitivity scanner to detect the fluorescent signals from the labeled glycoproteins. The intensity of each spot's signal correlates directly with the amount of a specific glycoprotein-lectin interaction, providing quantitative data.
The raw data is then processed through our advanced bioinformatics pipeline. Our experts analyze the data to identify and quantify differences in glycosylation patterns between sample groups, providing you with a comprehensive report.
DOI.: 10.1074/mcp.M116.059311
Journal: Molecular & Cellular Proteomics
IF: 5.5
Published: 2016
Results: This research developed the first human lectin microarray containing 60 recombinant human lectins and lectin-like proteins purified from yeast. Unlike conventional plant lectin arrays, this platform specifically targets human glycan recognition. Applied to analyze sperm surface glycosylation, the microarray identified strong binding interactions with galectin-1, -7, -8, GalNAc-T6, and ERGIC-53 (LMAN1). These findings were validated via flow cytometry and fluorescence immunostaining. Crucially, functional assays revealed that galectin-8 binding enhances the acrosome reaction in human sperm—a key fertilization process. Mass spectrometry further showed that galectin-1 interacts with membrane proteins like heat shock protein 90 (HSP90). This human-specific microarray offers a powerful tool for probing mammalian glycosylation mechanisms and their biological impacts.
Lectin binding protein microarray services decode glycan-binding specificities across diverse biological systems—revealing critical interactions in pathogen adhesion, immune regulation, and cancer biomarkers through high-throughput screening of immobilized lectins. To extend this static profiling into dynamic functional studies of glycan-mediated interactions under native membrane conditions, we offer Liquid Glycan Display Array (LiGA). This platform engineers fluidic membranes to mimic physiological cell-surface environments, enabling:
Quantifies multivalent interactions with tunable glycan density and mobility;
Tracks lectin diffusion and clustering on live membranes via single-molecule trajectories;
Measures real-time affinity shifts under shear stress or inhibitor exposure.
CD BioGlyco provides high-quality microarray tools and convenient detection services for studying lectin-related carbohydrate structure and glycoprotein analysis. We have a large and well-equipped team of scientists who are committed to cooperating with researchers from all over the world. By choosing outsourcing testing services, your advantage is that you do not need to consider any other expenses, such as equipment, laboratory space, supervision or management. This convenient method can quickly turn around and provide reliable results, thus saving valuable time and resources. Please contact us for more detailed information.
Reference